CWChristina A. Wilson

Christina A. Wilson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christina A. Wilson has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • David K. Stone

    First Physicians Group of Sarasota Memorial Health Care System (DKS), Sarasota, Florida; and Department of Neurology (NB, CAW), University of Florida, Gainesville, Florida

    2 shared publications
  • Koto Ishida

    Department of Neurology, NYU Langone Health, New York, NY

    2 shared publications
  • Natalie Buchwald

    Department of Neurology, University of Florida, Gainesville, FL, United States of America

    2 shared publications
  • Amita Singh

    Department of Neurology, University of Florida, Gainesville, FL, United States of America

    1 shared publication
  • B.P. Jackson

    Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA

    1 shared publication
  • Brett Cucchiara

    From the University of Pennsylvania Medical Center, Philadelphia, Pa

    1 shared publication

Latest Publications

  • Open Access

    Small-vessel disease in the brain

    by Amita Singh, Gabriel Bonnell, Justin De Prey, Natalie Buchwald, Kyrillos Eskander, Keith J. Kincaid, Christina A. Wilson


  • Updates in the Management of Cryptogenic Stroke and Patent Foramen Ovale

    by David K. Stone, Natalie Buchwald, Christina A. Wilson

    Background: Stroke is a common neurological disorder and may present with visual symptoms. A thorough workup is warranted to determine the underlying cause of stroke to optimize secondary prevention. Despite a full workup, a high-risk mechanism may not be identified. Optimal treatment in this patient population has been the subject of recent research, particularly with regard to low-risk stroke mechanisms such as patent foramen ovale (PFO). Evidence acquisition: Using PubMed and published stroke guidelines, an evidence-based literature review was performed. Results: In this review, we compare cryptogenic stroke with the newer concept of embolic stroke of undetermined source, summarize the most common causes presumed to underlie these strokes, and review the evidence for optimal antithrombotic management. We also review recent clinical trials demonstrating a benefit for percutaneous closure of PFO for secondary stroke prevention in select patients. Conclusions: Stroke management is based on evaluation of individual patient-risk factors. Evaluation and treatment is ideally directed by a vascular neurologist to ensure optimal secondary prevention, especially in cases where an underlying etiology is not identified on initial workup.


  • Management of Blunt Cerebrovascular Injury

    by David K. Stone, Vyas T. Viswanathan, Christina A. Wilson

    This review provides an updated summary of blunt cerebrovascular injury (BCVI) to guide clinicians in its early diagnosis and prevention and treatment of stroke associated with such injury.


  • Diagnostic Yield of Echocardiography in Transient Ischemic Attack

    by Christina A. Wilson, Waimei Tai, Jamsheed A. Desai, Ian Mulvihill, Jean-Marc Olivot, Sean Murphy, Shelagh B. Coutts, Gregory W. Albers, Peter Kelly, Brett L. Cucchiara


  • Etiology of Corpus Callosum Lesions with Restricted Diffusion

    by C.A. Wilson, M.T. Mullen, B.P. Jackson, K. Ishida, S.R. Messé

    Infarction of the corpus callosum is rare, and other conditions can cause magnetic resonance imaging (MRI) restricted diffusion in the callosum, leading to diagnostic uncertainty. We sought to characterize the etiology of lesions with diffusion restriction in the corpus callosum.


  • Convergent Validity and Interrater Reliability of Estimating the ABCD 2 Score From Medical Records

    by Koto Ishida, Jonathan M. Raser-Schramm, Christina A. Wilson, Scott E. Kasner, Michael T. Mullen, Steven R. Messe, Brett Cucchiara

    Background and Purpose—: The ABCD 2 score is increasingly used for risk stratification of transient ischemic attack patients. We sought to determine the reliability and convergent validity of retrospective ABCD 2 score estimation from medical records. Methods—: We compared ABCD 2 scores that were prospectively determined by a vascular neurology attending to scores determined retrospectively from medical record review. Emergency department records and neurology consult notes for patients with acute transient ischemic attack were abstracted with explicit ABCD 2 scoring redacted. Scores were estimated by 2 independent raters using these records. Estimated ABCD 2 component scores, total scores, and risk category were compared both between retrospective raters and with prospectively obtained scores. Reliability was assessed using unweighted κ statistics. Results—: Interrater reliability was substantial with 72% exact agreement in total score between retrospective raters (κ=0.64) and nearly perfect with 82% agreement for ABCD 2 category (κ=0.71). Interrater agreement was best for age and diabetes mellitus and poorest for clinical features and duration. Agreement between the retrospective raters and prospectively obtained score was >90% for age, blood pressure, and diabetes mellitus, but only ≈70% for clinical features and duration. Retrospectively, estimated total ABCD 2 score exactly matched the prospective score in 58% of patients for rater 1 and 44% of patients for rater 2. Retrospectively, estimated ABCD 2 category matched the prospectively scored category in 67% of patients for rater 1 and 71% of patients for rater 2. Conclusions—: The ABCD 2 score can be abstracted from medical records with substantial interrater reliability but limited convergent validity. This may lead to misclassification of risk category in more than one third of patients.